Cargando…
Increased expression of the high-mannose M6N2 and NeuAc3H3N3M3N2F tri-antennary N-glycans in cholangiocarcinoma
Changes in protein glycosylation have been reported in various types of cancer, including cholangiocarcinoma (CCA). Nanospray ionization-linear ion trap mass spectrometry (NSI-MS(n)) was used in the present study to determine the comparative structural glycomics of the N-linked glycans in the serum...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772869/ https://www.ncbi.nlm.nih.gov/pubmed/29399163 http://dx.doi.org/10.3892/ol.2017.7384 |
_version_ | 1783293475963273216 |
---|---|
author | Talabnin, Krajang Talabnin, Chutima Ishihara, Mayumi Azadi, Parastoo |
author_facet | Talabnin, Krajang Talabnin, Chutima Ishihara, Mayumi Azadi, Parastoo |
author_sort | Talabnin, Krajang |
collection | PubMed |
description | Changes in protein glycosylation have been reported in various types of cancer, including cholangiocarcinoma (CCA). Nanospray ionization-linear ion trap mass spectrometry (NSI-MS(n)) was used in the present study to determine the comparative structural glycomics of the N-linked glycans in the serum of patients with CCA compared with healthy controls. A total of 5 high-mannose and 4 complex N-linked glycans were detected. Mannose(7)-N-acetyl-glucosamine(2) was the most abundant structure among the high-mannose types (control 12.12±2.54 vs. CCA 9.27±2.66%), whereas NeuAc2H2N2M3N2 predominated the complex types (control 61.17±2.55 vs. CCA 64.68±4.23%). The expression of 3 different N-glycans differed significantly between the CCA cases and controls. These included mannose(6)-N-acetyl-glucosamine(2) (P=0.044), mannose(9)-N-acetyl-glucosamine(2) (Ρ=0.030) and NeuAc3H3N3M3N2F (Ρ=0.002). These three glycan structures may therefore be associated with tumor progression in CCA and may be useful for its diagnosis. |
format | Online Article Text |
id | pubmed-5772869 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-57728692018-02-02 Increased expression of the high-mannose M6N2 and NeuAc3H3N3M3N2F tri-antennary N-glycans in cholangiocarcinoma Talabnin, Krajang Talabnin, Chutima Ishihara, Mayumi Azadi, Parastoo Oncol Lett Articles Changes in protein glycosylation have been reported in various types of cancer, including cholangiocarcinoma (CCA). Nanospray ionization-linear ion trap mass spectrometry (NSI-MS(n)) was used in the present study to determine the comparative structural glycomics of the N-linked glycans in the serum of patients with CCA compared with healthy controls. A total of 5 high-mannose and 4 complex N-linked glycans were detected. Mannose(7)-N-acetyl-glucosamine(2) was the most abundant structure among the high-mannose types (control 12.12±2.54 vs. CCA 9.27±2.66%), whereas NeuAc2H2N2M3N2 predominated the complex types (control 61.17±2.55 vs. CCA 64.68±4.23%). The expression of 3 different N-glycans differed significantly between the CCA cases and controls. These included mannose(6)-N-acetyl-glucosamine(2) (P=0.044), mannose(9)-N-acetyl-glucosamine(2) (Ρ=0.030) and NeuAc3H3N3M3N2F (Ρ=0.002). These three glycan structures may therefore be associated with tumor progression in CCA and may be useful for its diagnosis. D.A. Spandidos 2018-01 2017-11-09 /pmc/articles/PMC5772869/ /pubmed/29399163 http://dx.doi.org/10.3892/ol.2017.7384 Text en Copyright: © Talabnin et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Talabnin, Krajang Talabnin, Chutima Ishihara, Mayumi Azadi, Parastoo Increased expression of the high-mannose M6N2 and NeuAc3H3N3M3N2F tri-antennary N-glycans in cholangiocarcinoma |
title | Increased expression of the high-mannose M6N2 and NeuAc3H3N3M3N2F tri-antennary N-glycans in cholangiocarcinoma |
title_full | Increased expression of the high-mannose M6N2 and NeuAc3H3N3M3N2F tri-antennary N-glycans in cholangiocarcinoma |
title_fullStr | Increased expression of the high-mannose M6N2 and NeuAc3H3N3M3N2F tri-antennary N-glycans in cholangiocarcinoma |
title_full_unstemmed | Increased expression of the high-mannose M6N2 and NeuAc3H3N3M3N2F tri-antennary N-glycans in cholangiocarcinoma |
title_short | Increased expression of the high-mannose M6N2 and NeuAc3H3N3M3N2F tri-antennary N-glycans in cholangiocarcinoma |
title_sort | increased expression of the high-mannose m6n2 and neuac3h3n3m3n2f tri-antennary n-glycans in cholangiocarcinoma |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772869/ https://www.ncbi.nlm.nih.gov/pubmed/29399163 http://dx.doi.org/10.3892/ol.2017.7384 |
work_keys_str_mv | AT talabninkrajang increasedexpressionofthehighmannosem6n2andneuac3h3n3m3n2ftriantennarynglycansincholangiocarcinoma AT talabninchutima increasedexpressionofthehighmannosem6n2andneuac3h3n3m3n2ftriantennarynglycansincholangiocarcinoma AT ishiharamayumi increasedexpressionofthehighmannosem6n2andneuac3h3n3m3n2ftriantennarynglycansincholangiocarcinoma AT azadiparastoo increasedexpressionofthehighmannosem6n2andneuac3h3n3m3n2ftriantennarynglycansincholangiocarcinoma |